| Entity Name: | XERIS PHARMACEUTICALS, INC. |
| Jurisdiction: | FLORIDA |
| Filing Type: | Foreign Profit |
| Status: |
Active
The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness. |
| Date Filed: | 22 Aug 2019 (6 years ago) |
| Document Number: | F19000003907 |
| FEI/EIN Number |
20-3352427
Federal Employer Identification (FEI) Number assigned by the IRS. |
| Address: | 1375 W Fulton Street, Suite 1300, Chicago, IL, 60607, US |
| Mail Address: | 1375 W Fulton Street, Suite 1300, Chicago, IL, 60607, US |
| Place of Formation: | DELAWARE |
| Name | Role | Address |
|---|---|---|
| CT CORPORATION SYSTEM | Agent | 1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324 |
| Pieper Steven M | Director | 1375 W Fulton Street, Chicago, IL, 60607 |
| Hecht Beth | Director | 1375 W Fulton Street, Chicago, IL, 60607 |
| Shannon John | Chief Operating Officer | 1375 W Fulton Street, Chicago, IL, 60607 |
| Shannon John | President | 1375 W Fulton Street, Chicago, IL, 60607 |
| Pieper Steven M | Chief Financial Officer | 1375 W Fulton Street, Chicago, IL, 60607 |
| Edick Paul M | Chief Executive Officer | 1375 W Fulton Street, Chicago, IL, 60607 |
| Event Type | Filed Date | Value | Description |
|---|---|---|---|
| CHANGE OF PRINCIPAL ADDRESS | 2024-03-28 | 1375 W Fulton Street, Suite 1300, Chicago, IL 60607 | - |
| CHANGE OF MAILING ADDRESS | 2024-03-28 | 1375 W Fulton Street, Suite 1300, Chicago, IL 60607 | - |
| Name | Date |
|---|---|
| ANNUAL REPORT | 2024-03-28 |
| ANNUAL REPORT | 2023-02-23 |
| ANNUAL REPORT | 2022-03-29 |
| ANNUAL REPORT | 2021-04-20 |
| ANNUAL REPORT | 2020-03-09 |
| Foreign Profit | 2019-08-22 |
Date of last update: 02 Apr 2025
Sources: Florida Department of State
